Saturday, May 24, 2008
Data Show Rufinamide, An Investigational Adjunctive Treatment For Lennox- Gastaut Syndrome, Reduced Drop Attacks By More Than 40%
Data Show Rufinamide, An Investigational Adjunctive Treatment For Lennox- Gastaut Syndrome, Reduced Drop Attacks By More Than 40% Eisai Corporation of North America announced the publication of a placebo-controlled study in Neurology that found patients with Lennox-Gastaut syndrome (LGS) treated with the investigational antiepileptic agent rufinamide as adjunctive therapy experienced more than 40% fewer drop attacks than patients who received placebo (increase of 1.4%). Source: www.medicalnewstoday.comPalatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL 3994 Palatin Technologies, Inc. (Amex: PTN) announced that dosing has been initiated in a Phase 2a clinical study of PL-3994, a novel, long-acting natriuretic peptide receptor A agonist, in subjects with controlled hypertension. The study is placebo-controlled and double-blinded, and will include up to five cohorts receiving escalating doses. Source: www.medicalnewstoday.comWhy Do Astronauts Suffer From Space Sickness? Centrifuging astronauts for a lengthy period provided researcher Suzanne Nooij with better insight into how space sickness develops, the nausea and disorientation experienced by many astronauts. Nooij defended her PhD theses on this subject at Delft University of Technology (TU Delft, The Netherlands) on Tuesday 20 May.Gravity plays a major role in our spatial orientation. Source: www.medicalnewstoday.comIronwood Pharmaceuticals And Forest Laboratories Announce Presentation Of Linaclotide Phase 2b Chronic Constipation Study Results Ironwood Pharmaceuticals, Inc. (formerly Microbia, Inc.) and Forest Laboratories, Inc. (NYSE: FRX) today announced the presentation of data from a Phase 2b randomized, double-blind, placebo-controlled study assessing the safety and efficacy of linaclotide in patients with chronic constipation (CC). Analysis of these data indicate that linaclotide met its primary endpoint. Source: www.medicalnewstoday.comThromboGenics Presents Further Results Of The Vitreomacular Traction Trial (MIVI IIT) At The Euretina Annual Meeting In Vienna Results Confirm the Beneficial effects of Microplasmin in Patients With Vitreomacular Traction Without Need for Vitrectomy Throughout the 6 Month Follow Up Period ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular and eye diseases, presented the Source: www.medicalnewstoday.comHIV Patients Suffer More From Osteoporosis Following the introduction of HAART (Highly Active Antiretroviral Therapy), the survival and quality of life for people infected with the human immunodeficiency virus (HIV-1) have increased in the resource-rich countries. However, with this improved prognosis an increase in long term negative disorders has been observed, namely osteoporosis (the gradual loss of bone mass). Source: www.medicalnewstoday.com
Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL 3994
Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL 3994 Palatin Technologies, Inc. (Amex: PTN) announced that dosing has been initiated in a Phase 2a clinical study of PL-3994, a novel, long-acting natriuretic peptide receptor A agonist, in subjects with controlled hypertension. The study is placebo-controlled and double-blinded, and will include up to five cohorts receiving escalating doses. Source: www.medicalnewstoday.comPivotal Study Shows Physician/Nurse Teams Using SEDASYS? System Reduced Risk Of Over Sedation With Propofol Ethicon Endo-Surgery announced that the results from its pivotal trial demonstrated physician/nurse teams using the SEDASYS? System reduced the risk of over sedation with propofol in patients undergoing screening and diagnostic procedures for colorectal cancer (colonoscopy), and disorders of the upper gastrointestinal tract (EGD). Source: www.medicalnewstoday.comDenosumab Osteoporosis Study Meets Primary And All Secondary Bone Mineral Density Endpoints In Alendronate (FOSAMAX(R)) Transition Study Amgen (NASDAQ: AMGN) announced findings from a head-to-head, double blind trial comparing the effects of denosumab in post-menopausal women with low bone mass transitioned from weekly alendronate (FOSAMAX(R)) versus continued alendronate therapy on bone mineral density (BMD). The study demonstrated superior results for the primary and all secondary endpoints. Source: www.medicalnewstoday.comAdvair Reduces Exacerbations In COPD Patients With A History Of Exacerbations The use of Advair Diskus(R) 250/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a 30% reduction in exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have a history of exacerbations as compared with salmeterol alone, according to new data Source: www.medicalnewstoday.comFirst Pre Pandemic Vaccine Approved To Help Protect Against Pandemic Influenza GlaxoSmithKline (GSK plc) announced that the European Commission has granted a marketing authorisation for its H5N1 adjuvanted pre-pandemic vaccine, Prepandrix?, in all 27 EU member states. Source: www.medicalnewstoday.comTelik Announces Initiation Of Two Phase 2 Randomized TELINTRA Studies Telik, Inc. (Nasdaq: TELK), announced it has initiated two Phase 2 TELINTRA(R) studies -- one with TELINTRA tablets in myelodysplastic syndrome, or MDS, and a second with TELINTRA tablets in cancer patients at risk for chemotherapy-induced neutropenia, or CIN. Source: www.medicalnewstoday.com
Thursday, May 22, 2008
DOJ Investigating Alabama Resort After Manager Prohibits HIV-Positive Child From Using Pool, Restrooms
DOJ Investigating Alabama Resort After Manager Prohibits HIV-Positive Child From Using Pool, Restrooms The Department of Justice is investigating Wales West RV Resort in Silverhill, Ala., in preparation for a possible discrimination lawsuit after a manager at the facility prohibited an HIV-positive child from using the facility's swimming pool and restrooms in July 2007, the Birmingham Press-Register reports (Bean, Birmingham Press-Register, 5/19). Source: www.medicalnewstoday.com'Trust Machinery' Identified In The Brain The brain centers triggered by a betrayal of trust have been identified by researchers, who found they could suppress such triggering and maintain trust by administering the brain chemical oxytocin. Source: www.medicalnewstoday.comUNICEF Assists Post-earthquake Child Support Mission The Government of China has organized a high level mission to Sichuan - with support from UNICEF - to provide immediate psycho-social assistance for children suffering emotional trauma following the major earthquake that struck the region on 12 May. Source: www.medicalnewstoday.comLife Insurance Policies Made Available To Sex Workers In India Commercial sex workers in India now have the option of purchasing life insurance policies, Smarajit Jana -- chief adviser to the group Durbar Mahila Samanwaya Committee, or the Committee for Indomitable Women -- said Monday, AFP/Yahoo! News reports. Source: www.medicalnewstoday.comDocumented Immigrants Protest Proposed Cuts To California's Medicaid Program Documented immigrants in California visited state legislators' offices on Monday to challenge proposed state budget cuts that would eliminate $86.7 million in preventive health care services for documented immigrants who have had green cards for less than five years, the Sacramento Bee reports. Gov. Source: www.medicalnewstoday.comSalute The Service Of Our Veterans And Families By Strengthening Their Support Networks Mental Health America is encouraging all Americans to salute the service of returning servicemen and women by strengthening support networks for our brave soldiers and their families as part of its 2008 May is Mental Health Month Connection Challenge. Although many soldiers remain on duty in Iraq and Afghanistan, some are returning home, along with reservists and members of the National Guard. Source: www.medicalnewstoday.com
Wednesday, May 21, 2008
UK MPs Vote To Keep 24 Week Abortion Limit
UK MPs Vote To Keep 24 Week Abortion Limit Last night, Tuesday 21st May, members of UK parliament's House of Commons voted to reject a proposal to reduce the upper limit for abortions from 24 to 22 weeks. Source: www.medicalnewstoday.comCOPD Patients Benefit More From Pulmonary Rehab In Earlier Stages Patients with chronic obstructive pulmonary disease (COPD) who are in their final years of survival do not get the same benefits from pulmonary rehabilitation (PR) as patients who have more years left to live - regardless of their age, complicating illnesses or lung function, according to new researc Source: www.medicalnewstoday.comA New Indicator For Esophageal Varix In Alcoholic Disease Variceal hemorrhaging is associated with a high mortality rate. The early detection of esophageal varices is critical for the effective prevention of variceal hemorrhage.In daily medical practice, it is common to encounter patients with liver damage from chronic alcohol consumption. When the alcoholic patient is examined, it is often evident that alcoholic liver damage is progressing. Source: www.medicalnewstoday.comBoston Globe Profiles Health Care Activist, Founder Of Black Women's Health Imperative The Boston Globe on Monday profiled the efforts of Byllye Avery, founder of the National Black Women's Health Project -- now known as the Black Women's Health Imperative -- and the Boston, Mass.-based Avery Institute for Social Change. Source: www.medicalnewstoday.com
Early Detection And Survival For Pancreatic Cancer Improved By New Research
Early Detection And Survival For Pancreatic Cancer Improved By New Research New research presented at Digestive Disease Week� 2008 (DDW�) showcases innovative methods to better understand the risk factors for and improve earlier detection of pancreatic cancer. Source: www.medicalnewstoday.com
Tuesday, May 20, 2008
Phase 3 TAK-390MR Data Demonstrates Higher Overall Healing Versus Lansoprazole In Patients With Erosive Esophagitis
Phase 3 TAK-390MR Data Demonstrates Higher Overall Healing Versus Lansoprazole In Patients With Erosive Esophagitis TAP Pharmaceutical Products Inc. reported results from three pivotal Phase 3 studies evaluating investigational new drug TAK-390MR, the first proton pump inhibitor (PPI) with an innovative dual delayed release technology, in healing patients with erosive esophagitis (EE) and in maintenance of healed EE. The data were presented at the Digestive Disease Week (DDW) annual meeting in San Diego. Source: www.medicalnewstoday.comMortality During Sepsis Reduced By Ashwell Receptor In research that solves the longest-standing mystery in glycobiology - a field that studies complex sugar chains called glycans - researchers at the University of California, San Diego School of Medicine have discovered that a molecule in the liver of all animals, called the Ashwell receptor, is crit Source: www.medicalnewstoday.comHow Not To Get Sick On Your Summer Trip Planning for a summer vacation is time-consuming business -- coordinating schedules, researching destinations, booking reservations, packing clothes. The last thing we want is to get sick while away from home, especially with illnesses that confine us to our room and render us unable to enjoy the vacation. Source: www.medicalnewstoday.comPhenomix Announces PHX1149 Phase 2b Clinical Trial Results For Type 2 Diabetes Phenomix Corporation announced that PHX1149, a dipeptidyl peptidase-4 (DPP-4) inhibitor, demonstrated positive results in a Phase 2b clinical trial for the treatment of Type 2 diabetes. The 12-week, double-blind, placebo-controlled clinical trial involving 422 randomized patients compared PHX1149 in once-daily oral doses of 200 milligrams and 400 milligrams to placebo. Source: www.medicalnewstoday.comSalix Pharmaceuticals Receives Approvable Letter From FDA For Balsalazide Tablet Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Company has received an approvable letter from the U.S. Food and Drug Administration (FDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older. Source: www.medicalnewstoday.comComputer-Based Simulation Program May Improve Asthma Patients' Care Mayo Clinic pulmonary researchers have designed and tested a new patient education computer program intended to help people with asthma manage their disease. The program allows asthma patients (an estimated 7 percent of the U.S. adult population) to practice making key decisions in a safe, simulated environment. Source: www.medicalnewstoday.comExtending British Crime Survey To Under 16s A Long Awaited Success, Says NCH, UK Commenting on the extension of the British Crime Survey to include under 16s and the Home Office initiative to find design solutions to prevent young people from becoming victims of crime, Clare Tickell, Chief Executive of NCH, the Children's Charity said: "From our work at NCH we know young peop Source: www.medicalnewstoday.comLink Between Ear Infections And Passive Smoking A new report from Perth's Telethon Institute for Child Health Research has found a strong link between childhood ear infections and exposure to tobacco smoke.The results are published in the latest edition of the Medical Journal of Australia. Source: www.medicalnewstoday.com
Sunday, May 18, 2008
25 Years Of HIV: Dr. Anthony Fauci Reflects
25 Years Of HIV: Dr. Anthony Fauci Reflects On the 25th anniversary of the first scientific article linking a retrovirus to AIDS, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, reflects in an essay in Nature on his experience treating and studying HIV/AIDS for the past quarter century. Source: www.medicalnewstoday.com
|
